AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32513116 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving standard care without the additional feedback from a medical specialist.
Number of subjects: 590
Study 34996113 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK3640254 10 mg
Number of subjects: 0
Study 34996113 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK3640254 40 mg
Number of subjects: 0
Study 34996113 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK3640254 80 mg
Number of subjects: 0
Study 34996113 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK3640254 140 mg
Number of subjects: 0
Study 34996113 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK3640254 200 mg
Number of subjects: 0
Study 34996113 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK3640254 (doses ≥40 mg)
Number of subjects: 0
Study 34996113 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study 34103405 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib modified-release 11 mg once daily plus methotrexate
Number of subjects: 694
Study 32854688 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT), performed twice a week for 12 weeks
Number of subjects: 82
Study 32854688 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT) supervised by mental health care providers with PA competence
Number of subjects: 82
Study 32854688 — intervention group
Group type: COMPARATOR
Intervention: Computer gaming skills training (control group)
Number of subjects: 82
Study 32854688 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT)
Number of subjects: 82
Study 36067506 — intervention group
Group type: EXPERIMENTAL
Intervention: Food supplement containing Cannabis sativa oil, Boswellia serrata Roxb. Phytosome®, and Zingiber officinale extract
Number of subjects: 0
Study 36067506 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32990376 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-Family Intervention (SFI)
Number of subjects: 43
Study 32990376 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-Family Groups (MFG)
Number of subjects: 43
Study 35943968 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Refocusing Treatment for Insomnia (CRT‐I)
Number of subjects: 82
Study 35943968 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulus Control Treatment (SCT)
Number of subjects: 82
Study 33684598 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA for 20 min over the primary motor cortex and contralateral supraorbital area)
Number of subjects: 104
Study 33684598 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 104
Study 33684598 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 104
Study 36102853 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenolization of the sinus tract(s)
Number of subjects: 100
Study 36102853 — intervention group
Group type: COMPARATOR
Intervention: Radical excision with primary wound closure
Number of subjects: 100
Study 36067977 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous auricular vagus nerve stimulation (taVNS)
Number of subjects: 0
Study 36067977 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study 32917925 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron replacement therapy (oral or intravenous)
Number of subjects: 96724
Study 32917925 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological assessments of iron status
Number of subjects: 96724
Study 34419666 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardioneuroablation (CNA) for VVS
Number of subjects: 118
Study 34419666 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient selection criteria for CNA
Number of subjects: 118
Study 34419666 — intervention group
Group type: EXPERIMENTAL
Intervention: Ablation strategy
Number of subjects: 118
Study 34419666 — intervention group
Group type: COMPARATOR
Intervention: RCT design
Number of subjects: 118
Study 34419666 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary outcome measure
Number of subjects: 118
Study 35669989 — intervention group
Group type: EXPERIMENTAL
Intervention: CP + aerobic VGE
Number of subjects: 39
Study 35669989 — intervention group
Group type: EXPERIMENTAL
Intervention: CP + breathing VGE
Number of subjects: 39
Study 35669989 — intervention group
Group type: COMPARATOR
Intervention: CP (control group)
Number of subjects: 39
Study 32898141 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET)
Number of subjects: 112
Study 32898141 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Behaviour and Network Therapy (SBNT)
Number of subjects: 112
Study 32898141 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 112
Study 36408812 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D kinematic bike fitting
Number of subjects: 162
Study 36408812 — intervention group
Group type: COMPARATOR
Intervention: Qualitative‐based riding posture recommendations
Number of subjects: 162
Study 34326046 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally competent systems intervention including three DVA training sessions from a GP educator and bilingual DVA advocate/educator, followed by 12 months of support for clinic staff and DVA affected women.
Number of subjects: 28
Study 34326046 — intervention group
Group type: COMPARATOR
Intervention: Routine DVA care with training in ethnicity and DVA data entry for comparison clinics.
Number of subjects: 28
Study 35099988 — intervention group
Group type: EXPERIMENTAL
Intervention: Slower intravenous fluid bolus rates
Number of subjects: 0
Study 35099988 — intervention group
Group type: COMPARATOR
Intervention: Faster intravenous fluid bolus rates
Number of subjects: 0
Study 33210279 — intervention group
Group type: EXPERIMENTAL
Intervention: Trisquel board game intervention program
Number of subjects: 0
Study 33546038 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (4 mg/6 h for 2 days, 4 mg/8 h for 2 days, 2 mg/6 h for 2 days, 2 mg/8 h for 2 days, 1 mg/8 h for 2 days, 1 mg/12 h for 2 days)
Number of subjects: 600
Study 33546038 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 600
Study 33546038 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 600
Study 35835435 — intervention group
Group type: EXPERIMENTAL
Intervention: Superior Capsular Reconstruction (SCR)
Number of subjects: 50
Study 35835435 — intervention group
Group type: COMPARATOR
Intervention: Bridging Graft (BG)
Number of subjects: 50
Study 35835435 — intervention group
Group type: EXPERIMENTAL
Intervention: SCR
Number of subjects: 50
Study 35835435 — intervention group
Group type: COMPARATOR
Intervention: BG
Number of subjects: 50
Study 35835435 — intervention group
Group type: EXPERIMENTAL
Intervention: SCR with intact grafts
Number of subjects: 50
Study 35835435 — intervention group
Group type: COMPARATOR
Intervention: BG with intact grafts
Number of subjects: 50
Study 32406111 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus + reduced-exposure tacrolimus (EVR + rTAC)
Number of subjects: 106
Study 32406111 — intervention group
Group type: COMPARATOR
Intervention: Mycophenolate mofetil + standard-exposure tacrolimus (MMF + sTAC)
Number of subjects: 106
Study 32936509 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual expert predictions
Number of subjects: 137
Study 32936509 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggregated expert predictions
Number of subjects: 137
Study 32936509 — intervention group
Group type: COMPARATOR
Intervention: Prediction algorithms guessing 50%
Number of subjects: 137
Study 32936509 — intervention group
Group type: COMPARATOR
Intervention: Prediction algorithms trained on base rates
Number of subjects: 137
Study 32936509 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual experts and aggregated predictions
Number of subjects: 137
Study 33067278 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary-based Qigong exercise
Number of subjects: 108
Study 33067278 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic band-based resistance exercise (RE)
Number of subjects: 108
Study 33067278 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined pulmonary-based Qigong exercise and elastic band-based RE
Number of subjects: 108
Study 33067278 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 108
Study 35348642 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunct AF surgery
Number of subjects: 352
Study 35348642 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 352
Study 34813490 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention video about sugar reduction narrated by a child (mean 1.99, SD 0.83)
Number of subjects: 4013
Study 34813490 — intervention group
Group type: EXPERIMENTAL
Intervention: Child narrator (mean 1.99, SD 0.87)
Number of subjects: 4013
Study 34813490 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician narrator (mean 1.95, SD 0.79)
Number of subjects: 4013
Study 34813490 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention videos
Number of subjects: 4013
Study 34813490 — intervention group
Group type: COMPARATOR
Intervention: Placebo video about sunscreen (mean 1.76, SD 0.69)
Number of subjects: 4013
Study 34813490 — intervention group
Group type: COMPARATOR
Intervention: Placebo video about earthquakes (mean 1.56, SD 0.63)
Number of subjects: 4013
Study 33383112 — intervention group
Group type: EXPERIMENTAL
Intervention: Aloe Vera vaginal cream
Number of subjects: 60
Study 33383112 — intervention group
Group type: COMPARATOR
Intervention: Estrogen vaginal cream
Number of subjects: 60
Study 32442828 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol
Number of subjects: 48
Study 32442828 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 36399023 — intervention group
Group type: EXPERIMENTAL
Intervention: E4 15 mg
Number of subjects: 180
Study 36399023 — intervention group
Group type: EXPERIMENTAL
Intervention: E4 5 mg
Number of subjects: 180
Study 36399023 — intervention group
Group type: EXPERIMENTAL
Intervention: E4 10 mg
Number of subjects: 180
Study 36399023 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 33245445 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) training
Number of subjects: 38
Study 33245445 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Standard of Care
Number of subjects: 38
Study 32079327 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-restricted feeding (TRF; 8 h/d)
Number of subjects: 11
Study 32079327 — intervention group
Group type: COMPARATOR
Intervention: Extended feeding (EXF; 15 h/d)
Number of subjects: 11
Study 36127651 — intervention group
Group type: EXPERIMENTAL
Intervention: 940 nm diode laser irradiation (0.5 W, 10 J/cm2, continuous-wave mode, 20 s)
Number of subjects: 25
Study 36127651 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 25
Study 33965257 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine (PCV7)
Number of subjects: 0
Study 33965257 — intervention group
Group type: COMPARATOR
Intervention: Haemophilus influenzae type b conjugate vaccine (Hib)
Number of subjects: 0
Study 32892187 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy in outpatient specialist healthcare
Number of subjects: 167
Study 32892187 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy in primary care
Number of subjects: 167
Study 32892187 — intervention group
Group type: COMPARATOR
Intervention: Overall cohort treatment
Number of subjects: 167
Study 36001131 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR) for 8 weeks
Number of subjects: 101
Study 36001131 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 101
Study 33677476 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) during stationary cycling sessions
Number of subjects: 12
Study 33677476 — intervention group
Group type: COMPARATOR
Intervention: No Virtual Reality (control condition) during stationary cycling sessions
Number of subjects: 12
Study 33159736 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid simulation method (Group A)
Number of subjects: 73
Study 33159736 — intervention group
Group type: COMPARATOR
Intervention: Conventional method (Group B)
Number of subjects: 73
Study 35219377 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg garadacimab
Number of subjects: 32
Study 35219377 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg garadacimab
Number of subjects: 32
Study 35219377 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 33875266 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated SARS-CoV-2 vaccine (50 EU)
Number of subjects: 192
Study 33875266 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated SARS-CoV-2 vaccine (100 EU)
Number of subjects: 192
Study 33875266 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated SARS-CoV-2 vaccine (150 EU)
Number of subjects: 192
Study 33875266 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study 33948743 — intervention group
Group type: EXPERIMENTAL
Intervention: High Transparency AI Explanation
Number of subjects: 3423
Study 33948743 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Transparency AI Explanation
Number of subjects: 3423
Study 33948743 — intervention group
Group type: EXPERIMENTAL
Intervention: Good AI Model
Number of subjects: 3423
Study 33948743 — intervention group
Group type: EXPERIMENTAL
Intervention: Weak AI Model
Number of subjects: 3423
Study 33948743 — intervention group
Group type: EXPERIMENTAL
Intervention: Agreement with AI predictions
Number of subjects: 3423
Study 33948743 — intervention group
Group type: EXPERIMENTAL
Intervention: Correctness of AI predictions
Number of subjects: 3423
Study 32924086 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping Power Programme (CPP) added to Parent Management Training (PMT)
Number of subjects: 120
Study 32924086 — intervention group
Group type: COMPARATOR
Intervention: Parent Management Training (PMT) only
Number of subjects: 120
Study 32502970 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar spine manipulation
Number of subjects: 3
Study 32502970 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 3
Study 616493118 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine (Cr) supplementation (0.3 g.kg‐1.d‐1 for 5 days followed by 0.1 g.kg‐1.d‐1 for 23 days)
Number of subjects: 17
Study 616493118 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 17
Study 35467612 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive rumination-based sports prescription (Experimental group)
Number of subjects: 61
Study 35467612 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 61
Study 35467612 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 61
Study 33245002 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ceftriaxone and metronidazole
Number of subjects: 50
Study 33245002 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (placebo)
Number of subjects: 50
Study 35509491 — intervention group
Group type: EXPERIMENTAL
Intervention: IV midazolam and syrup (Group S)
Number of subjects: 180
Study 35509491 — intervention group
Group type: COMPARATOR
Intervention: IV midazolam and water (Group C)
Number of subjects: 180
Study 34531205 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl (2 ?g/kg bolus, 1 ?g/kg/hour infusion up to 3 ?g/kg/hour)
Number of subjects: 97
Study 34531205 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ketamine (0.5 mg/kg bolus, intermittent bolus doses up to 2 mg/kg)
Number of subjects: 97
Study 34531205 — intervention group
Group type: EXPERIMENTAL
Intervention: Revised regimen of intravenous fentanyl (2 ?g/kg bolus, 2 ?g/kg/hour infusion up to 5 ?g/kg/hour)
Number of subjects: 97
Study 34531205 — intervention group
Group type: EXPERIMENTAL
Intervention: Revised regimen of intravenous ketamine (1 mg/kg bolus, intermittent bolus doses up to 4 mg/kg)
Number of subjects: 97
Study 34531205 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl (revised regimen)
Number of subjects: 97
Study 34531205 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ketamine (revised regimen)
Number of subjects: 97
Study 33351197 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine + Propofol (L + P)
Number of subjects: 48
Study 33351197 — intervention group
Group type: COMPARATOR
Intervention: Normal Saline + Propofol (NS + P)
Number of subjects: 48
Study 35288320 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical debridement (MD) followed by a single session of antimicrobial photodynamic therapy (aPDT)
Number of subjects: 34
Study 35288320 — intervention group
Group type: COMPARATOR
Intervention: Mechanical debridement (MD) alone
Number of subjects: 34
Study 32289619 — intervention group
Group type: COMPARATOR
Intervention: Statin treatment
Number of subjects: 1998
Study 32289619 — intervention group
Group type: COMPARATOR
Intervention: Diabetes status
Number of subjects: 1998
Study 32289619 — intervention group
Group type: EXPERIMENTAL
Intervention: High serum OPG levels
Number of subjects: 1998
Study 32289619 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustment for standard predictors
Number of subjects: 1998
Study 33905680 — intervention group
Group type: EXPERIMENTAL
Intervention: Early administration of antibiotics in a prehospital setting
Number of subjects: 0
Study 33905680 — intervention group
Group type: EXPERIMENTAL
Intervention: Early administration of antibiotics
Number of subjects: 0
Study 32474920 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum uric acid (UA) levels
Number of subjects: 633
Study 32474920 — intervention group
Group type: EXPERIMENTAL
Intervention: SNP rs1165196 on SLC17A1
Number of subjects: 633
Study 32474920 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted genetic risk score (wGRS)
Number of subjects: 633
Study 32474920 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis for SNP rs1165196
Number of subjects: 633
Study 32474920 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis for wGRS
Number of subjects: 633
Study 35366329 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-low-calorie diet
Number of subjects: 48
Study 33895733 — intervention group
Group type: EXPERIMENTAL
Intervention: PA (Physical Activity) intervention
Number of subjects: 80
Study 33895733 — intervention group
Group type: EXPERIMENTAL
Intervention: DIET (Dietary) intervention
Number of subjects: 80
Study 33895733 — intervention group
Group type: EXPERIMENTAL
Intervention: PA + DIET intervention
Number of subjects: 80
Study 33895733 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care plus education about PA and healthy eating)
Number of subjects: 80
Study 33895733 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions (PA, DIET, PA + DIET, Control)
Number of subjects: 80
Study 32131790 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program based on health belief model (HBM), 4 sessions in 1 month
Number of subjects: 120
Study 32131790 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study 33522376 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine co-administered with sodium nitroprusside
Number of subjects: 16
Study 33522376 — intervention group
Group type: COMPARATOR
Intervention: Ketamine co-administered with placebo
Number of subjects: 16
Study 32846174 — intervention group
Group type: EXPERIMENTAL
Intervention: Real 900 MHz RF‐EMF exposure for 26 min
Number of subjects: 26
Study 32846174 — intervention group
Group type: COMPARATOR
Intervention: Sham exposure for 26 min
Number of subjects: 26
Study 36303192 — intervention group
Group type: EXPERIMENTAL
Intervention: Single vocal cord irradiation (SVCI)
Number of subjects: 34
Study 36303192 — intervention group
Group type: COMPARATOR
Intervention: Transoral CO2-laser microsurgical cordectomy (TLM)
Number of subjects: 34
Study 34802788 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol supplementation (28,000 IU orally weekly for a maximum of 12 weeks)
Number of subjects: 40
Study 34802788 — intervention group
Group type: COMPARATOR
Intervention: Control group (vaccinated immediately after randomization)
Number of subjects: 40
Study 34802788 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol supplementation
Number of subjects: 40
Study 35857076 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-hand robot-assisted cholecystectomy (MRC)
Number of subjects: 166
Study 35857076 — intervention group
Group type: COMPARATOR
Intervention: da Vinci robot-assisted cholecystectomy (DRC)
Number of subjects: 166
Study 35857076 — intervention group
Group type: COMPARATOR
Intervention: Micro-hand robot-assisted cholecystectomy (MRC) and da Vinci robot-assisted cholecystectomy (DRC)
Number of subjects: 166
Study 34252155 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA methylation at locus cg03584380
Number of subjects: 180
Study 34252155 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA methylation at loci cg00076998, cg16758041, cg02365967
Number of subjects: 180
Study 34252155 — intervention group
Group type: EXPERIMENTAL
Intervention: Locus cg03584380
Number of subjects: 180
Study 34252155 — intervention group
Group type: EXPERIMENTAL
Intervention: Modules of loci
Number of subjects: 180
Study 32556204 — intervention group
Group type: EXPERIMENTAL
Intervention: Undercooled liquid emulsion (LE)
Number of subjects: 15
Study 32556204 — intervention group
Group type: COMPARATOR
Intervention: Partially crystalline solid emulsion (SE)
Number of subjects: 15
Study 36189723 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile health intervention for cardiovascular health promotion
Number of subjects: 26
Study 36189723 — intervention group
Group type: EXPERIMENTAL
Intervention: Enrolled churches
Number of subjects: 26
Study 36189723 — intervention group
Group type: COMPARATOR
Intervention: Non-enrolled churches
Number of subjects: 26
Study 33797949 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam (0.75 mg)
Number of subjects: 32
Study 33797949 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 32401189 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional null hypothesis significance testing (NHST)
Number of subjects: 90